CLINICAL_TRIALS
trial_result
· 2017-02-16
Clinical Trial Update: Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder [Phase 1]
Summary
Phase 1 safety and tolerability study of FK949E in adults with major depressive disorder has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Major Depressive Disorder Patients | Phase 1 | Status: COMPLETED